These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 10229198)
21. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218 [TBL] [Abstract][Full Text] [Related]
22. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637 [TBL] [Abstract][Full Text] [Related]
23. Insulin receptor expression and function in human breast cancer cell lines. Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559 [TBL] [Abstract][Full Text] [Related]
25. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474 [TBL] [Abstract][Full Text] [Related]
26. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Maloney EK; McLaughlin JL; Dagdigian NE; Garrett LM; Connors KM; Zhou XM; Blättler WA; Chittenden T; Singh R Cancer Res; 2003 Aug; 63(16):5073-83. PubMed ID: 12941837 [TBL] [Abstract][Full Text] [Related]
27. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800 [TBL] [Abstract][Full Text] [Related]
28. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Chisalita SI; Nitert MD; Arnqvist HJ Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer. Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046 [TBL] [Abstract][Full Text] [Related]
30. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Pacher M; Seewald MJ; Mikula M; Oehler S; Mogg M; Vinatzer U; Eger A; Schweifer N; Varecka R; Sommergruber W; Mikulits W; Schreiber M Carcinogenesis; 2007 Jan; 28(1):49-59. PubMed ID: 16774935 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor. Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143 [TBL] [Abstract][Full Text] [Related]
32. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394 [TBL] [Abstract][Full Text] [Related]
33. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
34. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours. Kornprat P; Rehak P; Rüschoff J; Langner C J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739 [TBL] [Abstract][Full Text] [Related]
35. Characterization of an antibody that can detect an activated IGF-I receptor in human cancers. Rubini M; D'Ambrosio C; Carturan S; Yumet G; Catalano E; Shan S; Huang Z; Criscuolo M; Pifferi M; Baserga R Exp Cell Res; 1999 Aug; 251(1):22-32. PubMed ID: 10438568 [TBL] [Abstract][Full Text] [Related]
36. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
37. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541 [TBL] [Abstract][Full Text] [Related]
38. 'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors. Rikhof B; van der Graaf WT; Suurmeijer AJ; van Doorn J; Meersma GJ; Groenen PJ; Schuuring EM; Meijer C; de Jong S Am J Pathol; 2012 Jul; 181(1):303-12. PubMed ID: 22658485 [TBL] [Abstract][Full Text] [Related]
39. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. Surmacz E; Bartucci M J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626 [TBL] [Abstract][Full Text] [Related]
40. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Osipo C; Dorman S; Frankfater A Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]